Medicare Expands ACCESS Pilot to Cover Digital Chronic Disease Management

Medicare is betting that the future of chronic disease management lives not in the clinic but on a patient's phone or home monitor. The Centers for Medicare & Medicaid Services is expanding its ACCESS model, a pilot program that reimburses digital health technologies for conditions like diabetes, heart disease, and musculoskeletal disorders—ailments that affect millions of older Americans and drive enormous costs through repeated office visits, emergency room trips, and hospitalizations.

The ACCESS model represents a deliberate shift in how Medicare pays for care. Rather than funding only the traditional visit—the doctor's appointment, the blood draw, the prescription refill—the program now covers remote monitoring systems, digital coaching platforms, and other tools that let patients track their conditions from home and get real-time feedback without traveling to a clinic. For a beneficiary managing congestive heart failure or arthritis, this means continuous data collection and intervention, not just episodic contact with the healthcare system.

The expansion is gaining momentum from unexpected quarters. CVS Health, the pharmacy and insurance giant, has joined forces with 14 other insurers to integrate behavioral health and musculoskeletal care technologies into the program. This coalition signals that private insurers see the same opportunity Medicare does: digital tools can reduce costs, improve outcomes, and keep patients engaged in their own care. RevelAi Health, a company focused on musculoskeletal conditions, has already been listed in Medicare's ACCESS Directory, one of the first vendors to gain formal recognition under the expanded framework.

What makes this expansion significant is its scope and timing. Medicare serves over 66 million people, many of them managing multiple chronic conditions simultaneously. The traditional model—quarterly or annual office visits—leaves enormous gaps where patients struggle alone, conditions worsen silently, and preventable crises land them in the hospital. Digital tools fill those gaps. A patient with diabetes can log blood sugar readings daily; an algorithm flags dangerous patterns; a nurse calls before a crisis happens. The math is straightforward: preventing one hospitalization pays for months of remote monitoring.

Yet the expansion also raises questions about fragmentation and coordination. When multiple vendors and insurers operate within the same ecosystem, will patient data flow seamlessly between systems? Will a primary care doctor actually see the musculoskeletal data collected by a separate platform? Will behavioral health insights inform physical care decisions? These are not rhetorical questions—they are the difference between a coordinated system that improves care and a collection of siloed tools that create more work for patients and clinicians.

The program's growth reflects a broader recognition that the healthcare system must adapt to an aging population with complex, long-term conditions. Chronic diseases account for roughly 90 percent of Medicare spending. If digital tools can even modestly reduce that burden—by catching problems earlier, reducing unnecessary visits, or helping patients stick to treatment plans—the return on investment is enormous. For Medicare, which operates under strict budget constraints, this is not altruism; it is necessity.

What happens next will depend on execution. The ACCESS model must prove that digital health technologies actually improve outcomes and reduce costs at scale, not just in controlled pilots. Vendors must build systems that talk to each other. Clinicians must learn to interpret and act on data flowing from home devices. Patients must trust the technology and use it consistently. None of this is guaranteed. But Medicare's decision to expand the program signals confidence that the pieces are falling into place—and that the future of chronic disease management will look fundamentally different from the past.